Please provide your email address to receive an email when new articles are posted on . The trial will include a headband device and neurobiomarker platform to conduct EEG and sleep analyses in those ...
CAMBRIDGE, Mass., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) (“Cyclerion” or "Company”), a biopharmaceutical company pioneering neuropsychiatric therapies, today ...
(A) Top and rear views of 9/64, 21/64, 32/128, and 66/256 electrode configurations. (B) Basic structure of the BCI system. The 200 targets were formed by combining 40 square luminance-modulated ...
Summary: Researchers dismantled the classic assumption that a person’s ability to easily fall asleep after a cup of coffee ...